The fund boosts the firepower of billionaire
Ackman, famed for aggressive moves such as a $1 billion bet
against U.S. nutrition firm Herbalife and a battle to broker a
sale of Botox maker Allergan to Valeant Pharmaceuticals.
The fund raised $2.73 billion through an initial public offering
and said the exercise of an over-allotment option would see the
value of the placing rise to more than $3 billion.
The fund was priced at $25 a share, giving it a market
capitalization of $6.2 billion, the company said in a statement.
Pershing Square Holdings' shares will start trading on Euronext
Amsterdam on Oct. 13.
The fund is run by Pershing Square Capital Management, a North
America-focused equities investment manager founded by Ackman in
2003 which had $14.1 billion in assets under management at the
end of June.
(Reporting by Francesco Canepa and Nishant Kumar; editing by
David Clarke)
[© 2014 Thomson Reuters. All rights
reserved.] Copyright 2014 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
|